Oragenics
OGEN
7 hedge funds and large institutions have $20.2M invested in Oragenics in 2015 Q2 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, 1 reducing their positions, and 3 closing their positions.
34% more capital invested
Capital invested by funds: $15.1M → $20.2M (+$5.11M)
0% less ownership
Funds ownership: 0% → 0% (-0%)
30% less funds holding
Funds holding: 10 → 7 (-3)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 3
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Janney Montgomery Scott
Philadelphia,
Pennsylvania
|
-$18.2K |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$17K |
| 3 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
-$15K |
| 4 |
VKH
Virtu KCG Holdings
New York
|
-$12K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$3K |
OGEN Hedge Fund Activity: Q2 2015 in Review
7 of the 3,712 institutional investors tracked by Wall St. Rank reported a position in Oragenics (OGEN) for Q2 2015, worth a combined $20.2M — up 34% from $15.1M a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of OGEN and 0 opened new positions — a net loss of 3 holders — while 1 trimmed existing stakes and 0 added.
The largest seller was Janney Montgomery Scott, cutting an estimated $18.2K.
- 7 institutional investors held Oragenics (OGEN) as of Q2 2015, down from 10 in Q1 2015.
- Funds reported $20.2M of Oragenics stock for Q2 2015, up 34% quarter-over-quarter.
- 0 funds opened new Oragenics positions in Q2 2015 and 3 closed out, a net change of -3 holders.
- The largest Oragenics seller in Q2 2015 was Janney Montgomery Scott, an estimated $18.2K sold.
Based on aggregated 13F filings for Q2 2015.